Take a careful look at the disclaimer. One it does not say what it is writing is true and further it clearing states that it may be (meaning it is) receiving compensation for writing the article. Said but true is is a OTC trick. The stock has down retreated to the closing PPS from yesterday. Investors need a PR directly from the company outlining exactly what it is doing now that October 1st has come and gone. How is MJ testing proceeding, growth of revenues resulting from Oregon's testing requirement, what is happening with the proceeds from all the dilution, when will CA's lab be acquired (LOI = hype until it happens)..
Investors do not need BS written for pay.